ARS Pharma Inc Live Stock Price Today, Share Analysis and Chart

Name: ARS Pharmaceuticals Inc: Is Infosys Ltd. worth buying?
Item: ARS Pharmaceuticals Inc
Rating: 1.16666675
Author: Trendlyne DVM scores

Momentum Trap

about

ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the commercialization and development of neffy (currently identified in the European Union (EU) and United Kingdom (U.K.) by the trade name EURneffy and in China) for needle-free intra...

8.96 0.21 (2.40%)

52.59% Fall from 52W High

436.2K

XNAS Volume

XNAS 04 Jun, 2026 2:21 PM (EDT)

Low Financial Strength

16.7 / 100

Expensive Valuation

9.0 / 100

Technically Neutral

51.0 / 100

Momentum Trap These stocks have weak financials and expensive valuation. Medium technical scores may weaken. Investors should exercise caution View Similar Embed DVM

1Yr Price target upside is 221%

5 analysts

ARS Pharma Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

ARS Pharma Inc Live Stock Price Today, Share Analysis and Chart

ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the commercialization and development of neffy (currently identified in the European Union (EU) and United Kingdom (U.K.) by the trade name EURneffy and in China) for needle-free intra...

52.59% Fall from 52W High

SWOT Analysis

ARS Pharma Inc Live Price Chart